Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31703898 | 0.84 | MAOA (0.38) | SLC6A2SLC6A4MAOA | |
| SCHEMBL28677353 | 0.81 | MEN1 (0.50) | MAOAMEN1KMT2A | |
| SCHEMBL16730447 | 0.80 | SLC6A2 (0.33) | SLC6A2SLC6A4 | |
| SCHEMBL13280554 | 0.76 | MEN1 (0.41) | SLC6A2SLC6A4MAOAMEN1KMT2A | |
| SCHEMBL11270154 | 0.72 | — | — | |
| SCHEMBL13280691 | 0.72 | CA12 (0.39) | SLC6A2SLC6A4MAOAKDM4E | |
| SCHEMBL30967714 | 0.69 | CAPN1 (0.35) | — | |
| SCHEMBL1230828 | 0.69 | MC4R (0.41) | SLC6A2SLC6A4MAOAKDM4EMEN1 | |
| SCHEMBL30967720 | 0.69 | OPRK1 (0.65) | OPRK1 | |
| SCHEMBL22593354 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9296688-B2 | Carbohydrate-selective receptors | NEW YORK UNIVERSITY (US) | 2016-03-29 | — | — | US | disclosed |
| US-20150141480-A1 | CARBOHYDRATE-SELECTIVE RECEPTORS | NEW YORK UNIVERSITY (US) | 2015-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141480-A1 | CARBOHYDRATE-SELECTIVE RECEPTORS | GPR119, GCGR, GALR1 | SLC6A2 803/4885SLC6A4 628/4885OPRK1 504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.